Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients
Cancer Management and Research May 21, 2018
Shang Z, et al. - Researchers ascertained the relationship between apolipoprotein A-I (Apo A-I) and overall survival (OS) as well as cancer-specific survival (CSS) in non-muscle-invasive bladder cancer (NMIBC) patients undergoing transurethral resection of a bladder tumour (TURBT). As per data, for therapeutic decision making in NMIBC patients, Apo A-I level could potentially serve as a useful prognostic indicator. Findings suggested an association of higher albumin, Apo A-I, and haemoglobin levels with greater OS and CSS, whereas, an association of elevated neutrophil-lymphocyte ratio with worse OS and CSS in the overall and high-risk population rather than low- and the intermediate-risk population was noted. Also, in the overall population and high-risk patients, Apo A-I was shown to be an independent predictor.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries